Plasticity-related gene 5: A novel surface autoantigen in paraneoplastic cerebellar degeneration
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 23, 2015
- Accepted in final form August 5, 2015
- First Published September 24, 2015.
Author Disclosures
- Marleen H. van Coevorden-Hameete, MD,
- Esther de Graaff, PhD,
- Maarten J. Titulaer, MD, PhD,
- Esther Hulsenboom, BSc,
- Lidia Sabater, BSc,
- Casper C. Hoogenraad, PhD and
- Peter A. Sillevis Smitt, MD, PhD
- Marleen H. van Coevorden-Hameete, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Esther de Graaff, PhD,
NONE
NONE
NONE
NONE
(1)co-investor: the detection anti-DNER antibodies
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maarten J. Titulaer, MD, PhD,
(1) Serve on the scientific advisory board of MedImmune LLC.
NONE
(1) Sun Pharma, travel grant for lecturing in India
(1) Neurology: Neuroimmunology & Neuroinflammation, since June 2014
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) supported by the Netherlands Organisation for Scientific Research (NWO, Veni incentive)
(1) Currently supported by an ErasmusMC fellowship
(1) supported by the Dutch Epilepsy Foundations, projectnumber 14-19.
NONE
NONE
NONE
NONE
NONE
NONE
- Esther Hulsenboom, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lidia Sabater, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Casper C. Hoogenraad, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Peter A. Sillevis Smitt, MD, PhD
NONE
NONE
NONE
NONE
Peter Sillevis Smitt is co-inventor of a pending patent on the detection anti-DNER
NONE
NONE
NONE
NONE
NONE
NONE
Peter Sillevis Smitt received a research grant from Euroimmun.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Biology (M.H.v.C.-H., E.d.G., C.C.H.), div Cell Biology, Utrecht University, Utrecht, the Netherlands; Department of Neurology (M.H.v.C.-H, M.J.T., E.H., P.A.S.S.), Erasmus Medical Center, Rotterdam, the Netherlands; and Service of Neurology Hospital Clinic (L.S.), Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
- Correspondence to Dr. Smitt: p.sillevissmitt{at}erasmusmc.nl
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.